Build a Defensible Clinical Evidence Strategy Under EU MDR
Build a defensible clinical evidence strategy under MDR Annex XIV, from the clinical evaluation plan to PMCF and notified body review.
Meditrial Editorial Team2026-09-25T15:31:40+00:00September 23rd, 2026|Categories: Clinical Trial, Compliance, EMA, Europe, European Union, MDCG, Medical Devices, Meditrial, Regulatory, Regulatory Affairs|
Build a defensible clinical evidence strategy under MDR Annex XIV, from the clinical evaluation plan to PMCF and notified body review.
Meditrial Editorial Team2026-09-17T10:24:52+00:00September 15th, 2026|Categories: Clinical Trial, EMA, EUDAMED, Europe, European Union, MDCG, Medical Devices, Meditrial, Regulatory, Regulatory Affairs|
Practical guidance on the CE mark for medical devices under EU MDR, from classification and evidence to conformity assessment and EUDAMED
Meditrial Editorial Team2026-09-21T14:42:22+00:00September 8th, 2026|Categories: Clinical Trial, Compliance, Medical Devices, Meditrial|
Risk-based quality management for medical device trials, with practical actions for risk assessment, monitoring, data review, and trial oversight
Become part of Meditrial! Subscribe to our newsletter.






Meditrial Europe - VAT CHE-115.033.718 © 2009 - 2026 | All Rights Reserved | Privacy | Terms of Use | Advertising Policy